셀바스헬스케어
2,410KRWMarket close of 10/21 (Wed)
Up +0.42%+10KRWMarket close of 10/21 (Wed)
- Open
- 2,410
- High
- 2,490
- Low
- 2,380
- Day range
- Day range low 2,380 high 2,490, open 2,410, close 2,410, previous close 2,400
- Volume
- 7×10K shares
- 158.31 million KRW 0.11× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
5%1-year close range 2,185 to 6,650 won, 5% up from the low
5% of the way up from the lowest close in 1 year (252 sessions) · -63.8% from the high
Usual range
Nothing unusual in the 4 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
- Daily moveusual range+0.42%+0.42%, 0.1× the usual (20-session average ±3.54%)That day +0.42% · usual ±3.54% · large-move threshold ±7.1%
The other 3 are within the usual range
- Trading value0.1×usual range
- EarningsOperating income, 8 quarters
- Data date10/21 (Wed)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue6.6B KRW
- vs. year ago
- -8.8%
- vs. prior quarter
- -35.4%
- Operating income668.55 million KRW
- vs. year ago
- +91.5%
- vs. prior quarter
- Turned profitable
- Operating margin10.2%
- vs. year ago
- +5.3 pp
- vs. prior quarter
- +10.4 pp
Quarterly operating income trend
As of the latest official close · 2026-10-21Valuation filing date · 2026-05-15Same sector · 의료·정밀기기
Up +2.11%· 56 of 101 stocks up, preferred shares excluded · trading value 249.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 나노엔텍 | Close over the last 20 sessions +10.6% | Up +8.13% | 39.0B KRW |
| 케이씨텍 | Close over the last 20 sessions +38.5% | Up +9.89% | 31.4B KRW |
| 디아이 | Close over the last 20 sessions +20.2% | Up +5.63% | 24.2B KRW |
| 티에스이 | Close over the last 20 sessions +9.5% | Up +3.42% | 20.1B KRW |
| 레메디 | Close over the last 20 sessions -0.3% | Up +4.50% | 19.6B KRW |
Schedule
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.